Across the globe, the COVID-19 pandemic continues to place enormous strains on the healthcare sector’s workforce, infrastructure and supply chain. However, since the beginning of 2020, COVID-19 has also accelerated changes, ushering in dynamic technologies, processes and systems that are delivering new standards of care.
This past year, technology pioneers and innovators in Ontario, Canada were among the many working to contain the virus—and they haven’t slowed down.
By using artificial intelligence (AI) applications, Ontario’s unique tech and life sciences ecosystems have been able to prepare for the future by building diverse platforms tailored to the needs of patient-centred care, all while unlocking value across the healthcare supply chain and beyond.
Learn why Ontario is a recognized global leader in the AI industry and about the impact our experts and ecosystem are making in the COVID-19 era. Ontario is cultivating the exceptional—contact us today to learn about what we can do to help your business succeed.
This Month's Highlights
On New Year’s Eve 2019, Ontario-based software company BlueDot pushed out a notification to its customers about a mysterious illness that appeared in Wuhan, China.
The startup, which grew out of Dr. Kamran Khan’s research at the MaRS Discovery District in Toronto, Ontario, combines natural language processing and machine learning to gather insights on the emergence and spread of infectious diseases around the globe. BlueDot was among the first to warn the world of a potentially dangerous new illness—now known as COVID-19—ringing the alarm before the U.S. Centers for Disease Control and Prevention and World Health Organization.
Today, Khan and his company are working with public health agencies and global enterprises to ensure that, before the next pandemic hits, governments, businesses and healthcare systems will be better prepared to move smarter and faster than ever before.
Roche, the world’s largest biotech company, continues to build on its history of success in Ontario. As Roche pushes the limits of science and technology to address healthcare needs, it is expanding its support for AI research.
In 2020, Roche announced it was creating a new Ontario-based AI centre of excellence in partnership with Canada’s leading AI research institutes: Toronto-based Vector Institute, the Alberta Machine Intelligence Institute and Montreal’s Mila. Through collaboration, the centre’s goal will be to drive AI advancements as they transform and optimize healthcare services in Canada and around the world.
Roche further put its trust in Ontario by announcing a new $500-million investment in a global pharma technical operations site at its Mississauga headquarters.
Learn why Roche chose Ontario, Canada to accelerate its global leadership in AI.
Novocol Pharma is a long-established sterile injectable fill-finish enterprise based in Cambridge, Ontario, providing clinical and commercial-scale manufacturing services for global customers.
With recent government investments, Novocol will increase biomanufacturingcapacity across Ontario and Canada, providing fill-finish sterile injectables including vaccines, therapeutics and a wide range of pharmaceuticals in a state-of-the-art GMP facility expansion.
By creating such capacity and capabilities, Novocol is committed to strengthening the world’s preparedness for future pandemics and is advancing the province’s burgeoning biopharmaceutical ecosystem.
The COVID-19 pandemic was devastating for many industries, but it only accelerated the use of AI across global economies. Amid the crisis, companies scrambled to create new services for remote workers and students, provide new and innovative online financial services options, offer indoor wayfinding and speed development of important healthcare technologies.
Even as machine learning and AI become commonplace, industry jargon makes it tough to identify some of the most competitive companies in the space.
We’re sharing 10 Ontario-based companies whose work demonstrates why our province is uniquely poised to lead the future of AI through 2021 and beyond.
Global management consulting firm Kearney has released its 2021 Foreign Direct Investment (FDI) Confidence Index, an in-depth view of forward-looking investment sentiment. In this year’s ranking, Canada moves up to the second spot, advancing from the third position in the 2019 FDI Confidence Index report.
According to the report, foreign investors found Canada’s stable governments, skilled workforce, advanced technology infrastructure and economic stability among our country’s most attractive features.
Learn why companies focused on the future are finding opportunities for growth in Canada.
Missed a newsletter? Be sure to check our archive of past newsletters.
Learn about Ontario's upcoming business events.
All company names and trademarks not owned by the Government of Ontario that appear on our website, are the property of and are protected by their respective owners.
Invest Ontario, 4th Floor, 2 Queen Street East, Toronto, Ontario, Canada M7A 1N3